Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer.

Yong WangBen-Jie ShanXia-Bo Shen Chang-Cheng ZhengJin-Quan WangGui-Ling LiYue-Yin Pan

Published in: Cancer management and research (2020)

Peripheral lymphocyte subset (CD3-positive and CD4-positive) on admission as a novel biomarker had a potential association with early efficacy. Cancer survivors in routine follow-up would achieve better short-term outcomes. COVID-19 patients with cancer should gain more attention and close monitoring.

Keyphrases

coronavirus disease
sars cov
emergency department
young adults
nk cells
working memory
respiratory syndrome coronavirus
peripheral blood
human health
chemotherapy induced